Lv11
40 积分 2024-07-18 加入
Analysis of China-to-West pharmaceutical licensing deals in 2024
16小时前
求助中
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
13天前
已完结
Reducing Delay in Retrial Queues by Simultaneously Differentiating Service and Retrial Rates
23天前
已完结
[Expert consensus on immunotherapy for small cell lung cancer (2025 edition)]
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
1个月前
已完结
Therapeutic Reprogramming toward Regenerative Medicine
1个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
5个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
5个月前
已完结
KRAS takes the road to destruction
5个月前
已完结
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
5个月前
已完结
皖公网安备34019202002308
